Loading…
Reported covered position: NONE
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Healthy Workforce Act of 2007
Client: CAMPAIGN TO END OBESITY ACTION FUND · Firm: VENN STRATEGIES
No Child Left Behind Reauthorization Healthy Workforce Act of 2007 (S. 1753)
Healthy Workforce Act of 2007
Client: CAMPAIGN TO END OBESITY ACTION FUND · Firm: VENN STRATEGIES
No Child Left Behind Reauthorization Healthy Workforce Act of 2007 (S. 1753)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Source: Senate LDA
| SOUTHERN ALLIANCE FOR CLEAN ENERGY ACTION FUND |
| 14 |
| 2007–2010 |
| ROUNDTABLE ON CRITICAL CARE POLICY | 11 | 2010–2015 |
| AMERINET INC | 9 | 2005–2010 |
| PARTNERSHIP FOR PART D ACCESS | 9 | 2021–2023 |
| VISITING NURSE ASSOCIATIONS OF AMERICA | 8 | 2014–2015 |
| MCILHENNY COMPANY | 7 | 2005–2007 |
| THRIVENT FINANCIAL FOR LUTHERANS | 7 | 2005–2007 |
| EMERSON | 6 | 2005–2007 |
| AMSTED INDUSTRIES | 5 | 2005–2007 |
| COMMUNITY HOSPICE PARTNERSHIP | 5 | 2011 |
| S CORPORATION ASSOCIATION | 5 | 2005–2007 |
| THE PHILANTHROPIC COLLABORATIVE | 5 | 2008–2009 |
| FREDDIE MAC - FEDERAL HOME LOAN MORTGAGE CORPORATION | 4 | 2005–2007 |
| GCI GROUP | 4 | 2005–2007 |
| HUBBARD BROADCAST CORPORATION INC | 4 | 2005–2007 |
| METLIFE | 4 | 2005–2007 |
| NATL ASSN OF BROADCASTERS | 4 | 2005–2006 |
| PACIRA PHARMACEUTICALS, INC. | 4 | 2018–2019 |
| SAMMONS ENTERPRISES | 4 | 2005–2007 |
| UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION/UW HEALTH | 4 | 2005–2007 |
| ALLIANCE TO PRESERVE AMERICAN EXPORTERS | 3 | 2007 |
| AMERICAN COUNCIL FOR ENGINEERING COMPANIES | 3 | 2007 |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIAITON (AOPA) | 3 | 2005 |
| CHARITABLE ACCORD | 3 | 2005 |
| FERRELL COMPANIES INC | 3 | 2006–2007 |
| HOSPIRA INC | 3 | 2007 |
| IKARIA HOLDINGS | 3 | 2009 |
| MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY | 3 | 2007 |
| NATIONAL ALLIANCE FOR BETTER NUTRITION | 3 | 2019–2020 |
| SAN FRANCISCO BAY AREA RAPID TRANSIT DISTRICT | 3 | 2006–2007 |
| UNITED WAY WORLDWIDE | 3 | 2022 |
| BELL SOUTH | 2 | 2005–2006 |
| BOSTON SCIENTIFIC CORPORATION | 2 | 2005 |
| SWINGVOTE | 2 | 2005 |
| NATL HOUSING TRUST | 1 | 2005 |
| PHRMA | 1 | 2005 |
Healthy Workforce Act of 2007
Client: CAMPAIGN TO END OBESITY ACTION FUND · Firm: VENN STRATEGIES
No Child Left Behind Reauthorization Healthy Workforce Act of 2007 (S. 1753)
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2026 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2026 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · fourth_quarter · 4A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2025 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to health insurance coverage through Medicaid and the Affordable Care Act, and measures to prevent amputation.
Advocate for access to affordable therapies and technology, and efforts to preserve access to health care coverage for people with diabetes and prediabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2025 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2025 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Advocate for access to affordable therapies and technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Advocate for access to affordable therapies and technology.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · second_quarter · Q2
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2024 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · first_quarter · Q1
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2024 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes and pre-diabetes, including but not limited to measures to advance the prevention of unnecessary amputations and affordable access to medication.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2023 · second_quarter · Q2
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · 1A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · 1A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2023 · first_quarter · Q1
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2023 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2023 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · 4A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · 3A
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · 4A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · 3A
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · fourth_quarter · Q4
Support for 211 line; CMS comment preparation
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2022 · fourth_quarter · Q4
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · third_quarter · Q3
Support for 211 line; CMS comment preparation
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2022 · third_quarter · Q3
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2022 · third_quarter · Q3
Legislation impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE via VENN STRATEGIES
2022 · third_quarter · RR
Federal funding strategy, support for 211 line; tax and healthcare policy.
Federal funding strategy, support for 211 line; tax and healthcare policy.
Federal funding strategy, support for 211 line; tax and healthcare policy.
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2022 · second_quarter · Q2
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · second_quarter · Q2
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2022 · first_quarter · Q1
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2022 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2022 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2021 · fourth_quarter · Q4
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2021 · fourth_quarter · Q4
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2021 · third_quarter · Q3
Healthcare policies affecting Americans living with diabetes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2021 · third_quarter · Q3
Issues related to ensuring patient access to medications under the Medicare Part D program, specifically those in the six protected classes.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR PART D ACCESS via VENN STRATEGIES
2021 · second_quarter · RR
Issues related to protecting access to needed medications under the Medicare Part D program, notably the six protected classes.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2021 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · 1T
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · RA
Manufacturer of thermal, carbonless, and security paper.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · 4T
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Q3
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Q2
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2020 · first_quarter · Q1
Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR BETTER NUTRITION via VENN STRATEGIES
2020 · first_quarter · Q1
Issues related to the 2020 Dietary Guidelines for Americans.
Issues related to the 2020 Dietary Guidelines for Americans.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2020 · first_quarter · Q1
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · first_quarter · Q1
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via VENN STRATEGIES
2020 · first_quarter · RR
Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.
NATIONAL ALLIANCE FOR BETTER NUTRITION via VENN STRATEGIES
2019 · fourth_quarter · Q4
Issues related to the 2020 Dietary Guidelines for Americans.
Issues related to the 2020 Dietary Guidelines for Americans.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · fourth_quarter · Q4
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2019 · fourth_quarter · Q4
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR BETTER NUTRITION via VENN STRATEGIES
2019 · fourth_quarter · RR
Issues related to the 2020 Dietary Guidelines for Americans.
Issues related to the 2020 Dietary Guidelines for Americans.
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · third_quarter · Q3
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2019 · third_quarter · Q3
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Q2
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · second_quarter · Q2
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2019 · first_quarter · Q1
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2019 · first_quarter · Q1
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VOICES FOR NON-OPIOID CHOICES via VENN STRATEGIES
2019 · second_quarter · RR
Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.
CAMPAIGN TO END OBESITY ACTION FUND via VENN STRATEGIES
2018 · first_quarter · 1A
General issues related to policy to prevent and treat U.S. obesity.
General issues related to policy to prevent and treat U.S. obesity.
The budget related to federal spending on obesity policy and programs.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · fourth_quarter · Q4
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CAMPAIGN TO END OBESITY ACTION FUND via VENN STRATEGIES
2018 · fourth_quarter · Q4
General issues related to policy to prevent and treat U.S. obesity.
General Issues related to policy to prevent and treat U.S. obesity.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Q4
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2018 · third_quarter · Q3
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CAMPAIGN TO END OBESITY ACTION FUND via VENN STRATEGIES
2018 · third_quarter · Q3
General Issues related to policy to prevent and treat U.S. obesity.
General issues related to policy to prevent and treat U.S. obesity.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · second_quarter · Q2
Issues related to the import and manufacture of lightweight thermal and carbonless paper.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2018 · second_quarter · Q2
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CAMPAIGN TO END OBESITY ACTION FUND via VENN STRATEGIES
2018 · second_quarter · Q2
General issues related to policy to prevent and treat U.S. obesity.
General Issues related to policy to prevent and treat U.S. obesity.
The budget related to federal spending on obesity policy and programs.
Federal funding strategy, support for 211 line; tax and healthcare policy.
General issues related to policy to prevent and treat U.S. obesity.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE